Dr. Raghavan Chinnadurai earned Ph.D. in Human Biology at the University of Ulm in Germany, did postdoctoral fellowship in immunology at Emory University, Georgia, United States. Subsequently, he served as a staff scientist at the University of Wisconsin in Madison. Currently, Dr. Chinnadurai is an Assistant Professor at the Department of Biomedical Sciences at Mercer University School of Medicine in Georgia where his primary responsibilities are research and teaching. Dr. Chinnadurai leads a research laboratory which aims to understand the immunobiology, functions and cell therapy applications of Mesenchymal Stem/Stromal Cells (MSCs) in inflammatory disorders/cancer. Dr. Chinnadurai published more than 30 research articles focusing on MSCs, which define the characteristics, phenotype, potency, and functionality of MSCs in various clinical conditions. He received awards and fellowships including, 2013 Young Investigator Award at the International Society for Cell Therapy regional meeting, American Liver foundation fellowship, Winship Cancer Institute Gala Scholar Award and WES-Leukemia Research foundation young investigator award. Dr. Chinnadurai is also an honorary member at the Atlanta Pediatrics Research Alliance in Georgia. Dr. Chinnadurai serves as an associate coeditor in specialty section of Frontiers in Immunology, Next Generation MSC Therapy Manufacturing, Potency and Mechanism of Action Analysis. In addition to research, Dr. Chinnadurai also teaches immunology curriculum to the first year Doctor of Medicine (MD) Students. Dr. Chinandurai’s laboratory is populated with MD, graduate, and undergraduate students, and he enjoys mentoring them with a hope to train them as future physicians and scientists and harnessing the power of MSC based cellular and regenerative therapy in academic medicine. A few recent publications from his laboratory are mentioned below.
• Contrariety of Human Bone Marrow Mesenchymal Stromal Cell Functionality in Modulating Circulatory Myeloid and Plasmacytoid Dendritic Cell Subsets. Biology (Basel). 2023 May 16;12(5). PMID: 37237538
• Conglomeration of T and B Cell Matrix Responses Determines the Potency of Human Bone Marrow Mesenchymal Stromal Cells. Stem Cells. 2022 Dec 31;40(12):1134-1148. PMID: 36056823.
• Chemokine Assay Matrix Defines the Potency of Human Bone Marrow Mesenchymal Stromal Cells. Stem Cells Transl Med. 2022 Sep 21;11(9):971-986. PMID: 35881077.
